Blog

Almost every article about shilajit and women leads with the same list: energy, hormonal balance, skin health, bone density, and fertility. The claims are not false, but most of them are based on male RCTs, animal models, or traditional use rather than clinical studies specifically in women. And the one benefit that is robustly supported in women, iron absorption, is almost never mentioned because it doesn't fit the "female vitality" marketing narrative.

This article covers what the evidence actually supports for women, where the gaps are, and the two specific situations where shilajit is particularly useful for women that no competitor is talking about.

Why shilajit research is male-skewed, and what that means for women

The clinical research on shilajit has a clear demographic bias. The landmark testosterone study (Andrologia, 2016) used men aged 45–55. The athletic performance study (JISSN, 2019) used male subjects. The erectile function studies are inherently male. This reflects a pattern across supplement and pharmaceutical research, women are systematically underrepresented in clinical trials, rather than a biological fact about who benefits from shilajit.

The mechanisms that produce shilajit's primary effects are not sex-specific. Mitochondrial energy enhancement through fulvic acid's electron transport facilitation works identically in male and female cells. Mineral transport improvement through fulvic acid's chelation properties is not hormonal or sex-dependent. Anti-inflammatory activity through NF-kB pathway modulation applies across sexes. The male framing in shilajit marketing is a commercial decision, the testosterone supplement market is larger and more brand-loyal than the women's supplement market, not a reflection of who the compound works for.

What the evidence actually supports for women

Energy and fatigue reduction, strong. The mitochondrial mechanism is the most consistently reproduced finding in shilajit research. Fulvic acid facilitates electron transfer in the mitochondrial electron transport chain, increasing ATP production at the cellular level. Women experience fatigue as a primary health complaint at significantly higher rates than men, driven by iron deficiency, thyroid conditions, hormonal fluctuations, and chronic inflammation. The mitochondrial mechanism addresses the cellular energy production layer regardless of the upstream cause. A woman with iron-deficiency-driven fatigue benefits from both the iron absorption improvement and the direct mitochondrial support simultaneously.

Cognitive function, strong. Fulvic acid's neuroprotective properties have been studied specifically in the context of Alzheimer's disease prevention, with research demonstrating that fulvic acid inhibits the aggregation of tau protein, one of the pathological hallmarks of Alzheimer's. Women develop Alzheimer's at higher rates than men and have a longer lifetime risk. The cognitive clarity and focus improvements that shilajit users commonly report are consistent with the neuroprotective and mitochondrial energy mechanism, and the protective implications are particularly relevant for women given their elevated lifetime risk.

Anti-inflammatory activity, strong. Chronic low-grade inflammation underlies many of the conditions that disproportionately affect women, autoimmune conditions, endometriosis, polycystic ovary syndrome, thyroid disorders. Shilajit's anti-inflammatory mechanisms, including reduction of inflammatory cytokines and modulation of immune response, are mechanism-based rather than sex-specific. Clinical extrapolation from the available research is reasonable.

Skin and hair health, moderate. The collagen-supporting mineral content (zinc, copper, selenium) and antioxidant protection from fulvic acid have a reasonable mechanistic basis for skin and hair benefits. These are not strongly clinically validated in direct shilajit studies but are consistent with what is known about the roles of these minerals and the anti-oxidative effects of fulvic acid.

Hormonal balance, limited direct evidence. One study showed modest DHEA improvement in men taking shilajit; there is no equivalent RCT in women. Traditional Ayurvedic use for female reproductive health is extensive but predates modern clinical methodology. This is a reasonable traditional claim that needs proper female-specific research before it can be made with confidence.

The iron connection, shilajit's most underrated benefit for women

Iron deficiency is the most common nutritional deficiency globally, and women bear the overwhelming burden of it. Menstruation, pregnancy, and breastfeeding all create significant iron demands that diet alone frequently cannot meet. An estimated 30% of women globally are iron deficient, with rates substantially higher among women of reproductive age in India and South Asia.

Standard iron supplementation addresses the deficit but comes with well-documented side effects, constipation, nausea, and gastrointestinal discomfort that leads many women to stop taking it. Fulvic acid's ability to chelate iron into a more bioavailable, better-tolerated form addresses both problems simultaneously. The 2010 study found that women taking shilajit alongside iron supplementation not only recovered haemoglobin levels faster but reported fewer gastrointestinal side effects than those taking iron alone. The mechanism is that fulvic acid binds iron in a chelated form that the intestinal wall absorbs more efficiently and with less direct mucosal irritation.

This has a practical implication: women with confirmed iron deficiency who are struggling with iron supplement side effects may find shilajit a useful adjunct that improves the efficacy of a smaller iron dose, producing the desired haemoglobin improvement without the digestive cost of a full-dose iron supplement.

Important: If you are already taking iron supplements, do not add shilajit without consulting your doctor, the improved absorption may push iron levels higher than intended. Test ferritin levels before and during use.

Hormones and PCOS, what to know before taking it

The hormonal claims around shilajit for women are where the most caution is warranted, not because the claims are necessarily false, but because the research is insufficient to say either way.

For women with PCOS: Shilajit has been shown to modestly raise DHEA levels (based on male studies). DHEA is a precursor to both testosterone and oestrogen. For women with PCOS who already have elevated androgens, this could be counterproductive. For women with PCOS who have low DHEA and are experiencing fatigue and low libido, it could be beneficial. The same effect is either helpful or harmful depending on the individual's specific hormonal profile, which means PCOS is not a contraindication, but it warrants getting your DHEA levels checked before starting and monitored during use.

For perimenopause and menopause: The traditional Ayurvedic use of shilajit for female reproductive health transitions has a long history, and the mineral and adaptogenic support it provides, particularly for the bone density and cognitive concerns that accompany oestrogen decline, has mechanistic support. No RCTs specifically in peri or postmenopausal women have been published, but this is one of the more promising areas for future female-focused shilajit research.

Pregnancy and breastfeeding: Do not use during pregnancy or while breastfeeding. The safety data simply does not exist to support this. Traditional use cautions against it during pregnancy, and modern safety standards require demonstrated safety in this population before recommendation, which shilajit does not currently have.

Dose, timing, and what to expect

Dose: 300–500mg/day of purified resin is the studied dose range. For women, starting at the lower end, a small pea-sized portion, roughly 300mg, for the first two weeks allows you to assess tolerance before increasing. There is no established evidence that higher doses produce proportionally greater benefits, and the mitochondrial and iron absorption mechanisms are consistent at the standard dose range.

Timing: Morning with warm water or warm milk, with breakfast or shortly before. The energy and mitochondrial effects are most useful during the active day. Avoid taking at night, the energy-supporting effects can interfere with sleep in some people.

What to expect and when: Iron absorption improvements and haemoglobin changes require 6–8 weeks to manifest in measurable improvements. Energy and cognitive clarity are typically noticeable earlier, within 2–4 weeks for most people. Anti-inflammatory effects accumulate over 8–12 weeks of consistent use. Do not assess at two weeks and conclude it isn't working, the relevant clinical studies ran for 90 days minimum.

Quality matters significantly. Impure or unprocessed shilajit may contain heavy metals, mycotoxins, and other contaminants. The raw resin must be purified before use. Always choose a supplier who provides third-party testing for heavy metals and specifies fulvic acid percentage. Fulvic acid content of 60–80%+ is the marker of a high-quality purified resin.

Frequently asked questions

The bottom line

Shilajit is a legitimately useful supplement for women, but the reasons are different from the male-testosterone narrative that dominates shilajit marketing. For women specifically, the most evidence-backed benefits are energy and fatigue reduction through the mitochondrial mechanism, iron absorption improvement (the most underreported and clinically important benefit for women globally), cognitive protection, and anti-inflammatory support. The hormonal claims require more female-specific research before they can be made with confidence.

The dose is the same as for men: 300–500mg/day of purified resin with a high fulvic acid percentage. Start at the lower end. Give it the full 90 days before assessing. Do not use during pregnancy or breastfeeding. Women with PCOS should check baseline hormone levels before starting and monitor during use.